NVCR · Forms 3, 4, 5

Insider trades at NovoCure Ltd

No open-market insider buys or sells at NovoCure Ltd in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for NovoCure Ltd (NVCR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Most recent insider filings

No Form 3, 4 or 5 filings for NovoCure Ltd in the last 90 days. The latest ones on EDGAR:

DateInsiderRoleTransactionSharesPriceValueFiling
Michal Nath PuriChief Human Resources OfficerAward1,905$11.15$21KForm 4
Frank X LeonardChief Executive OfficerAward1,905$11.15$21KForm 4
Arye Barak BenGeneral CounselAward1,299$11.15$14KForm 4
Asaf DanzigerDirectorAward268$11.15$3KForm 4
Frank X LeonardChief Executive OfficerSell34,273$17.93$615KForm 4
Gabriel LeungDirectorAward11,610Form 4
Kristin StaffordDirectorAward11,610Form 4
Allyson J OceanDirectorAward11,610Form 4
Timothy J ScannellDirectorAward11,610Form 4
Jeryl L HillemanDirectorAward11,610Form 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.